Why Clarification & Harmonisation of the Bolar Exemption and an Explicit Prohibition of Patent Linkage Is Needed in the European Union

31 October 2023

Policy

IQVIA – Assessing the Biosimilar Void

30 October 2023

External Resource

While biosimilar competition in Europe has played a vital role […]

Review of Nitrosamine Drug Substance Related Impurities (NDSRI) in Pharmaceutical Drugs

30 October 2023

Report

European strategic stockpile

11 October 2023

Factsheet

Market review Biosimilar medicines policy 2023 – Policy Statement

27 September 2023

Policy

Biosimilars Market Review 2023

18 September 2023

Report

Market review Generic medicines policy 2023 – Policy Statement

29 June 2023

Policy

Generic Market Review 2023

29 June 2023

Report

Position on the Proposal for a Regulation of the European Parliament and of the Council on Packaging and Packaging Waste

19 June 2023

Policy

Review of the SPC Manufacturing Waiver: a First Industry Report

13 June 2023

Report